SOLICITATION NOTICE
B -- Collection of formalin Fixed Tissue Blocks and Melanoma Lesion Pathology Reports
- Notice Date
- 8/22/2014
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02CP42644-61
- Archive Date
- 9/20/2014
- Point of Contact
- KATHY D. ELLIOTT, Phone: 240-276-5570, Seena Ninan, Phone: 240-276-5419
- E-Mail Address
-
ELLIOTTK@MAIL.NIH.GOV, ninans@mail.nih.gov
(ELLIOTTK@MAIL.NIH.GOV, ninans@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Genetic Epidemiology Branch (GEB), plans to procure on a sole source basis services from University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences, Via Vetoio, Coppito 2, 67100, l'Aquila, Italy, for the collection of formalin fixed tissue blocks and melanoma lesion pathology reports. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b) (1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541990 and the business size standard is $14.0M. Only one award will be made as a result of this solicitation; and the contract type will be a firm fixed price. The Period of Performance: Performance shall be twelve months with one (1) twelve month option period. It has been determined that there are no opportunities to acquire green products or services for this procurement. The Division of Cancer Epidemiology and Genetics (DCEG) is an intramural research program of the National Cancer Institute (NCI), National Institutes of Health (NIH) that conducts population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The Genetic Epidemiology Branch (GEB) has been investigating epidemiological and genetic factors associated with melanoma risk in a case-control study of melanoma conducted at the University of L'Aquila. The purpose of this requirement is to support the collection of formalin fixed tissue blocks and related pathology reports and clinical data from melanoma cases previously examined for epidemiological and genetic variant associations with melanoma risk. The Genetic Epidemiology Branch (GEB) has successfully conducted an analysis of epidemiological and genetic factors associated with melanoma risk in a case-control study of melanoma conducted at the University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences. The GEB needs to collect melanoma tissue blocks from the same melanoma cases from which the branch has examined epidemiological and genetic risk factors, in order to correlate these data with molecular changes across tumors. The proposed contractor has experience in following screening criteria for nevi and pigmentation characteristics and epidemiological data collection. The staff have been trained in the recognition of dysplastic nevi and melanoma as well as pathological features of melanoma lesions and can ensure continuity in the research. The contractor has surgeons that can verify the melanoma diagnoses by reviewing the pathology reports from the pathologists of the L'Aquila University. In addition, the proposed staff has expertise in the practical aspects involved in the management of data, clinical forms, informed consents, and biospecimens according to NCI standard and operating procedures and can ensure optimal quality of the collected data. Finally, the contractor has access to medical and pathological records from the same melanoma patients previously analyzed at NCI, which is pivotal to the completion of this project. Based upon these factors the Department of Biotechnological and Applied Clinical Sciences at the University of L'Aquila is the only know contractor that can fulfill the requirements of this contract. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, especially small businesses, they may submit a tailored statement of capabilities via fax or email. In addition, all responsible sources may submit a bid, proposal, or quotation which shall be considered by the NCI. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. All information must be received in the NCI contracting office on or before 4:00 PM EST on September 5, 2014. All questions must be in writing and can be faxed (240) 276-5401 or emailed to Kathy Elliott, Contracts Specialist at Elliottk@mail.nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the System for Award Management (SAM) www.sam.gov. No collect calls will be accepted. Please reference solicitation number N02CP42644-61 on all correspondences.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02CP42644-61/listing.html)
- Place of Performance
- Address: NIH / National Cancer Institute, Rockville, Maryland, 20850, United States
- Zip Code: 20850
- Zip Code: 20850
- Record
- SN03476340-W 20140824/140822234607-acb5a960faec0db686137fec9f3ae03d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |